Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-07-30 16:02:55 ET · period of report 2026-07-29 · accession 0001674236-26-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-07-30 16:02 | 2026-07-29 | ANIP | CAREY STEPHEN P. | SVP, CFO | S - Sale | $81.36 | -2,850 | 174.7K | -2% | -$231.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-29 | S | D | 2,850 | $81.36 | 174,693 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. (F2) The shares were sold in multiple trades at prices ranging from $80.61 to $81.88. The price reported above reflects the weighted average sales price. |